Invest-NL invests in revolutionary microsurgical technology from Microsure

The broader adoption of microsurgery and improved precision and control during operations reduce complications and lead to lower healthcare costs.

Microsure's robotic microsurgery technology is revolutionary because it makes most complex microsurgeries accessible to almost all surgeons. The robotic technology surpasses human capabilities in terms of precision, stability, and control in microsurgery, enabling the execution of the most complex microvascular procedures. By minimizing human hand movements and filtering out natural tremors, it becomes possible to suture even tiny blood vessels that are invisible to the naked eye.

New and existing investors

In this funding round, several new private and public investors are participating, such as the European Innovation Council Fund (EICF), Swiss-based Kineo, and various prominent private investor groups. Existing investors, including the deep-tech venture capital fund Innovation Industries, BOM Ventures, private investors Ten Cate Investment Company (TCIM), Venturing Tech, Eindhoven University of Technology (TU/e), and the founders of Microsure, continue their support.

Koen van Breugel, investment manager at Invest-NL: “Invest-NL makes fundable what seems unfundable. This is particularly true for our role in this investment round, which is clinically, technically, and commercially challenging and therefore risky. Investing in high-tech developments requires significant capital investments and often a long-term vision. We are pleased to have contributed to the success of this funding round.”

We previously published a story about Microsure.